Biography

Dr Sean Wasserman is a clinical academic in infectious diseases at St George’s, University of London. He has a clinical research programme on treatment optimisation for TB and HIV-associated opportunistic infection. His work on linezolid characterised the relationship between drug exposure and toxicity, identifying a PK target for therapeutic drug monitoring. Work in TB meningitis includes investigating site of disease drug exposure through PK studies in pre-clinical models and patient cohorts. Dr Wasserman co-leads the REVIVE trial evaluating azithromycin prophylaxis for advanced HIV, and the Rifastrat trial for treatment shortening in drug-susceptible TB.